Figure 2: Creating living drugs with injectable synthetic nanoparticles.

Schematic diagram illustrating genetic reprogramming of immune cells in situ using genes carried by polymeric nanoparticles. These particles are coated with ligands that target them to therapeutically desired immune cell subsets, so once infused into the patient’s circulation they can transfer the genes they carry into the target cells.